Jenn Powell speaks with MS Influencer, Tyler Campbell
In 2007, Tyler Campbell, son of Hall of Fame legend, Earl Campbell, was diagnosed with Multiple Sclerosis while playing football at San Diego State University. He continued to play football while keeping his diagnosis a secret. Unfortunately, shortly after his NFL Pro Day at San Diego, Tyler experienced a major setback that landed him in the hospital and in a wheelchair, unable to walk. After t...
56m Jan 27, 2022
56m
T20K Peptide Shows Promise in MS Preclinical Studies & Managing Challenges With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS). Price also reads the column by Jamie Hughes, A Life in Letters, “When Is a Wall Not Just a Wall?”. =================================== Are you interest...
8m Jan 26, 2022
8m
Large Study Links Mono to Greater Risk of MS & Conversations With an MS Carer
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a population-based study tied infectious mononucleosis (EBV) in childhood or adolescence to a roughly 2-to-3 times greater MS risk as adult.  Also, Price Wooldridge, reads the column by John Connor, Fall Down, Get Up Again, “An Interview With My Primary Carer”. =================================== Are you in...
8m Jan 24, 2022
8m
Cold May Ease MS Inflammation and Disease Severity & Aquatic Therapy for Chronic Back Pain
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mice kept for two weeks at 10 C (50 F) showed lesser MS-like symptoms and inflammation than others, likely due to body's response to cold. Price also reads “Aquatic Therapy for Chronic Back Pain”, column by Ed Tobias. =================================== Are you interested in learning more about multiple scl...
9m Jan 21, 2022
9m
Owlytics’ MS Smartwatch Goes Through First Validation Stage & Tools to Manage MS Symptoms
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Owlytics’ provided scientific evidence that the smartwatch may be used as a measure of response to a treatment in a clinical trial. Plus, reads “Curing Headaches, Pain, and Stress, One Gizmo at a Time”, a column by Jamie Hughes. =================================== Are you interested in learning more about m...
8m Jan 19, 2022
8m
Stem Cells Fail to Reduce Brain Inflammation in Active MS & Switching MS Carers Temporarily
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses treatment with mesenchymal stem cells or MSCs in adults with active MS failed to significantly reduce brain inflammation, trial data show. Plus, reads the column by John Connor, Fall Down, Get Up Again, “There’s a New Primary Carer in Town”. =================================== Are you interested in learning more...
11m Jan 17, 2022
11m
Brain Volume, NfL Level Changes May Predict Disability in Relapsing MS & COVID Vaccines and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an early MRI measures of brain atrophy and serum NfL levels may accurately predict progression for relapsing forms of MS, a study suggests. Also, Price reads “More Answers About COVID-19 Vaccines and MS”, a column by Ed Tobias. =================================== Are you interested in learning more about multip...
11m Jan 14, 2022
11m
MS Society Backs Stem Cell Transplant for Aggressive RRMS & Living With MS Isn't Something to Hide
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how younger RRMS patients (under 50) whose active disease fails to respond to DMT use might consider a patient-derived bone marrow transplant. Also, Price reads "“Kintsugi Reminds Me That Living With MS Isn’t Something to Hide”", a column by Jamie Hughes. =================================== Are you interested in...
9m Jan 12, 2022
9m
Innodem and Novartis to Test Eye-tracking Technology & Managing Certain MS Accidents
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Innodem and Novartis Canada are launching a clinical trial to evaluate biomarker eye-tracking technology for monitoring MS progression. Plus, Price reads “My Coffee Cup Runneth Over, Plus a Darned Interruption”, a column by John Connor. =================================== Are you interested in learning more...
9m Jan 10, 2022
9m
Hydroxychloroquine Appears to Treat PPMS & How to Exercise with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with the anti-malaria medication hydroxychloroquine may help slow disability progression among people with PPMS. Price Wooldridge, reads the column by Jamie Hughes, A Life in Letters, “Just Put One Foot in Front of the Other”. =================================== Are you interested in learning more...
10m Jan 07, 2022
10m
PBS Subsidies in Australia Will Lower Cost of Kesimpta & Why You Matter to the MS Community
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how people in Australia with multiple sclerosis (MS) and certain other medical conditions will have access to new and expanded medications — including Kesimpta — now listed on the Pharmaceutical Benefits Scheme (PBS). Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Celebrity or Not, You Matter t...
8m Jan 05, 2022
8m
One Year of Ocrevus Not Linked to Higher Risk of Brain Infection & The Healing Powers of THC
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads an article about how one year of Ocrevus (ocrelizumab) treatment does not increase the risk of a rare brain infection known as PML in people with MS, a study suggests. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “On the Healing Powers of THC”. =================================== Are you int...
9m Jan 03, 2022
9m
Evobrutinib Could Help with Relapsing MS & How Planning Can Help Manage Life with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib reduced the size of inflammation-associated brain lesions in a Phase 2 trial in relapsing multiple sclerosis. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Being Prepared Can Help Us Succeed”. =================================== Are you interested in learning m...
11m Dec 31, 2021
11m
Jenn Powell Talks To Cyndi Zagieboylo from the National Multiple Sclerosis Society
Since 1985 Cyndi Zagieboylo has dedicated her life’s work to achieving National Multiple Sclerosis Society’s vision of a world free of MS. While serving on the Society's National Board of Directors as CEO and president, Cyndi serves on the Multiple Sclerosis International Federation CEO Advisory Group and Board of Trustees. A founding member of the International Progressive MS Alliance launched...
31m Dec 30, 2021
31m
Deep Brain Stimulation May Help with MS Tremors & Embracing MS Through Tattoos
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how deep brain stimulation effectively reduces tremors in people with multiple sclerosis, according to a review study. Plus, Price Wooldridge, reads “Permanent Ink: My Tattoo Serves as an Important Reminder”, a column by Jamie Hughes. =================================== Are you interested i...
9m Dec 29, 2021
9m
Myc Gene Can Boost Efficiency of Myelin-repairing Cells & Managing the Threat of Covid
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how increasing the activity of the Myc gene can make myelin-repairing cells more efficient, a finding that may help advance MS treatments, a study says; and reads the column by John Connor, Fall Down, Get Up Again, “I’m Back in the Desert Without a Horse”. =================================== Are...
8m Dec 27, 2021
8m
CALLIPER Trial for Progressive MS Enrolls First Patient & The Benefits of Sun Exposure
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how Immunic Therapeutics has enrolled a patient in the Phase 2 clinical trial CALLIPER, testing oral IMU-838 for progressive MS; and reads the column by Ed Tobias, MS Wire, “Sun-seeking Finds Support in New Study.” =================================== Are you interested in learning more about multiple sclerosis? ...
8m Dec 24, 2021
8m
Potential Relapsing MS Therapy Up for FDA Approval & Trying a New Diet with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how TG Therapeutics is seeking FDA approval for ublituximab, its anti-CD20 monoclonal antibody infusion therapy for RRMS and SPMS with relapses; and reads the column by Jamie Hughes, A Life in Letters, “Listening to My Body as I Experiment With a New Diet”. =================================== Are you interested ...
9m Dec 22, 2021
9m
NervGen Brings Advanced Imaging to Upcoming Trials & Socializing with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about how NervGen will use Imeka's biomarker imaging technology to measure changes in brain and spinal cord in its Phase 1b/2 trials. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “Party on, Dude, but I’m Still Blaming the Dog!” =================================== Are you inte...
8m Dec 20, 2021
8m
Cognitive Rehab Is Effective Therapy for MS Cognitive Issues & Managing an MS Bladder
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how cognitive rehabilitation is an effective, low-risk and low-cost approach to treating cognitive problems of multiple sclerosis, study found; and reads the column by Ed Tobias, MS Wire, “I’m Back on the MS ‘Bladder Coaster’.” =================================== Are you interested in learning more about multipl...
7m Dec 17, 2021
7m
First Patient Enters Extension Trial Testing Higher Temelimab Doses & How to Hold Space with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how the first patient who completed GeNeuro’s ProTEct-MS Phase 2 trial has entered the study's extension, which will test higher doses of temelimab. Also, Price reads the column by Jamie Hughes, A Life in Letters, “You Don’t Always Need to Fix It”. =================================== Are yo...
8m Dec 15, 2021
8m
Mesenchymal Stem Cells Show Promise in Preclinical Studies & When MS Feels Like Groundhog Day
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how mesenchymal stem cells can improve functional abilities and promote the remyelination in rodent models of MS, according to a meta-analysis. Plus, reads a column by John Connor, Fall Down, Get Up Again, “Groundhog Day, Groundhog Day, Groundhog Day, Groundhog Day.” Are you interested in learning more about mul...
9m Dec 13, 2021
9m
Cancer Researchers’ Discovery May Benefit MS Research & Five Years of Lemtrada Treatment
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how in an unexpected discovery, scientists found that increasing the activity of PDGFRA reduces the production of myelin in the nervous system; and reads the column by Ed Tobias, MS Wire, “My Lemtrada Treatment, 5 Years Later.” =================================== Are you interested in learning more about multipl...
10m Dec 10, 2021
10m
Light-sensing Protein Could Explain Role of Seasons in MS Risk & Managing Good and Bad Days
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how a light-sensing protein present in the brain during fetal development may help explain why MS is more common among people born in spring. Plus, Price reads the column by Jamie Hughes, A Life in Letters, “Making the Most of Both Good Days and Bad”. Are you interested in learning more about multiple sclerosis?...
9m Dec 08, 2021
9m
Tecfidera Excels at Reducing RRMS Relapse Rate & Managing the Bad Days with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or injectable immunomodulators. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “It’s Just One of Those MS ‘Snow Days’.” =================================== Are you interested...
8m Dec 06, 2021
8m
Stopping Fingolimod for Pregnancy Raises Relapse Risk & Singing Can Benefit People with MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how women with relapsing-remitting MS who stop fingolimod – sold as Gilenya – to conceive or in early pregnancy have a higher relapse risk. Also, Price reads “Once More, With Feeling: How Singing Can Benefit MS Patients”, a column by Jamie Hughes. =================================== Are you interested in learni...
12m Dec 03, 2021
12m
Jenn Powell Talks to MS Twins and Advocates Tamara Kahn and Terry Hord
Jenn Powell speaks with identical twins with MS Tamara Kahn and Terry Hord. Meet identical twins Tamara Kahn and Terry Hord. Identical in every way, both were diagnosed with multiple sclerosis twenty plus years ago. These two amazingly close sisters created “TwinsCoast2Coast” to inspire, empower, support, and educate others about the challenges of MS while also showing the positives that have ...
39m Dec 02, 2021
39m
MS Could Increase Risk After Colorectal Diagnosis & Fertility and MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that indicates how people who develop colorectal cancer are more likely to die from it if they have multiple sclerosis. Also, Price reads “MS and Fertility: Conflicts of the Heart and Mind”, a column by Beth Ullah. =================================== Are you interested in learning more ...
8m Dec 01, 2021
8m
Anti-CD20 Therapies Show Similar Safety And Efficacy in RRMS & Wheelchair Mishap
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about how anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with RRMS Also, Price reads “Thanks to a Wheelchair Mishap, I was ‘Busy Goin’ Nowhere’, a column by John Connor. =================================== Are you interested in lear...
10m Nov 29, 2021
10m
Oral Treatment Can Ease MS Bladder Problems & Could Mono Help Research MS?
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how oral fesoterodine fumarate tablets can reduce urinary disorders and improve quality of life for people with bladder impairment due to MS. Price also reads “Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS?”, a column by Ed Tobias. =================================== Are you int...
9m Nov 26, 2021
9m
Vumerity Recommended for EU Approval as RRMS Therapy & Coping with Expected Loss
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how European Medicines Agency committee is recommending that Vumerity be approved for adults with relapsing-remitting multiple sclerosis in the EU; plus, Price reads the column by Jennifer Powell, Silver Linings, “When Loss Is Expected, How Do We Cope?”. ===================================== ...
7m Nov 24, 2021
7m
Rim Lesions Common in People with MS & Attending A Family Gathering With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how rim lesions, thought to indicate chronic brain inflammation, were found in about 4 of every 10 patients; declined with age, disease duration; and reads “Despite the Nerves, I Attended My First Family Gathering in 2 Years”, a column by John Connor. =================================== Treatment for Relapsing M...
10m Nov 22, 2021
10m
Class of Molecules May Offer Opioid Alternative for Treating Pain & Sleeping Better With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about a class of molecules called positive allosteric modulators (PAMS) may be used to treat pain caused by nerve damage, a common symptom of MS. Price also reads a column by Ed Tobias, MS Wire, “I’m Sleeping Better These Days, but Why?”. =================================== Treatment for Relapsing MS...
11m Nov 19, 2021
11m
Nurses Recommend Proactiveness in Managing Bladder and Bowel Issues & Overcoming A Fear Of Concerts
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article on how bladder and bowel problems should be monitored regularly in MS patients to better adapt treatment plans and improve quality of life; plus, reads “Overcoming My Fear of Concerts With a Little Help From the Rolling Stones”, a column by Jennifer Powell. =================================== Treatmen...
10m Nov 17, 2021
10m
Chronic Inflammation in MS Linked to Specific Brain Cells & Trying New Lymphedema Wraps
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how chronic Inflammation in MS can be linked to specific brain cells, a recent study showed; and also reads “All Change Please, the Medical Equipment You’re Using Ends Here”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod...
11m Nov 15, 2021
11m
Depression in MS Patients Raises Risk of Vascular Disease and Death & COVID-19 Booster Shot
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how a study found MS and depression doubled patients' vascular disease risk over 10 years, and relative to controls greatly raised risk of death. Also, Price Wooldridge, reads “I’m Grateful for My COVID-19 Booster Shot”, a column by Ed Tobias. =================================== Treatment f...
11m Nov 12, 2021
11m
Certain Conditions More Common In Immigrants with MS & Emotional, Physical Pain: Unwanted Sidekicks
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses an article about on how a study of immigrants with MS to Ontario, relative to residents with MS, found mood disorders and other comorbidities prevalent. Also, Price reads “Emotional and Physical Pain Are My Unwanted Sidekicks”, a column by Jennifer Powell. =================================== Treatment for Relaps...
11m Nov 10, 2021
11m
Immune Cells Harm Myelin-producing Cells & A Weekend Of Tooth Agony
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how pro-inflammatory T helper 17 (Th17) immune cells directly interact with myelin-producing cells, promoting their damage and death. Price also reads “The Painful Tooth: My Weekend of Agony”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | ...
11m Nov 08, 2021
11m
T. Gondii Parasite May Protect Against Developing MS & Can Low Temperatures Reduce MS Inflammation?
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how people who had been infected with the T. gondii parasite were 32% less likely to develop multiple sclerosis than those who had not. Price also reads the column by Ed Tobias, MS Wire, “Researchers Lower the Temperature to Try to Reduce MS Inflammation”. =================================== Treat...
10m Nov 05, 2021
10m
#InstagramLive: Who's Behind The MS News Today Social Media Platforms? Part 2
Follow us on social media! Instagram - https://www.instagram.com/msnewstoday/ Twitter - https://twitter.com/MSNewsToday Facebook - https://www.facebook.com/multiplesclerosisnewstoday/ Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with Ed Tobias (@themswire) and Arelis Castillo (@msconstruedfashion) about their roles as the social media coord...
56m Nov 04, 2021
56m
#InstagramLive: Who's Behind The MS News Today Social Media Platforms? Part 1
Follow us on social media! Instagram - https://www.instagram.com/msnewstoday/ Twitter - https://twitter.com/MSNewsToday Facebook - https://www.facebook.com/multiplesclerosisnewstoday/ Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with two of the folks behind MS News Today’s online community, Rochelle (@thisisrochelle) and Desiree Lama (@thed...
56m Nov 04, 2021
56m
Vibration Training Also Seen to Aid Cognition and Life Quality in Study
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how patients who had six weeks of vibration training have showed better cognitive function and life quality, and lesser disability in a small study; and reads “As My Disease Progresses, I Choose to Grow”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS Progression | MA...
10m Nov 03, 2021
10m
National MS Society Invests $8.7M in Research, Clinical Trial Training
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how National MS Society investments support 29 training fellowships, early career awards, and research projects aligned with its Pathways to Cures Roadmap; and reads “He’s Fallen in the Water!”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponi...
13m Nov 01, 2021
13m
ADS-5102 Aided Walking Speed in Select MS Patients in INROADS Trial & It’s Flu Vaccine Time Again
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about a how a Phase 3 trial analysis showed ADS-5102 significantly increased walking speed in 21% MS patients with difficulties; further work stopped. Also, Price Wooldridge reads “It’s Flu Vaccine Time Again, So Here’s What You Need to Know”, a column by Ed Tobias. ===============================...
13m Oct 29, 2021
13m
Interview With Kevin Schaefer, Director of Forums for SMA News Today
Jenn Powell speaks with Director of Forums for SMA News Today, Kevin Schaefer Director of Forums for SMA News Today, Kevin Schaefer started at BioNews in 2017 as a columnist for SMA News Today, sharing his experiences as an adult with SMA Type 2. He eventually transitioned to a full-time role, helping build the company’s multimedia and forums divisions. Join Jenn and Kevin as they discuss com...
49m Oct 28, 2021
49m
Serious Infections in Adolescence Linked to Increased MS Risk & Talking About Restless Legs Syndrome
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about experiencing serious infections during adolescence and how this can be tied to an increased risk of developing multiple sclerosis later in life. Price also reads “When Restless Legs Syndrome Won’t Leave You Alone”, a column by Jennifer Powell. =================================== Treatment f...
11m Oct 27, 2021
11m
Brain Atrophy, Serum NfL Levels May Predict Cognition Early in MS & A Difficult Week For John Connor
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about neurofilament light chain blood levels and cortical thinning on MRIs in recently diagnosed RRMS patients linked with poorer cognitive tests; and reads the column by John Connor, Fall Down, Get Up Again, “Down and Out in London Town!”. =================================== Treatment for Relapsi...
9m Oct 25, 2021
9m
BioNews Clinical Will Bring Trials Into ‘Continuum’ of MS Care & Ed Tobias' 50th College Reunion
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare and chronic disorders who want to participate. Price also reads “3 Things I Discovered at My 50th College Reunion”, a column by Ed Tobias. =================================== Treatment for Relaps...
13m Oct 22, 2021
13m
i-Belong App Aims to Expand Online MS Patient Communities
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Belong.Life's, a new i-Belong app that allows health professionals, advocacy groups, pharmas and others to build and manage patient communities. He also reads “Next Time, Ask Me Why I Need and Accessible Parking Placard”, a column by Jennifer Powell. =================================== Treatmen...
7m Oct 20, 2021
7m
Combo of Biomarkers Predicts Future Disease Activity & John Connor Gets A New Hairstyle
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how high levels of neurofilament light chain (NfL) protein combined with thinning of the retina can be a strong indicator of future disease activity; and reads the column by John Connor, Fall Down, Get Up Again, “Lockdown Blues: Well That Was a Close Shave!”. =================================== ...
15m Oct 18, 2021
15m